A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer

Division of Health Behavior Research, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63108, USA.
Breast Cancer Research and Treatment (Impact Factor: 3.94). 05/2010; 124(3):835-44. DOI: 10.1007/s10549-010-0912-1
Source: PubMed


Breast cancer patients' perceived risk of recurrence has been associated with psychological distress. Little is known about the change of patients' perceived risk of recurrence over time and factors associated with their recurrence-risk perceptions. We prospectively recruited 549 newly diagnosed early-stage breast cancer patients; patients completed interviews at 6 weeks, 6 months, 1 year, and 2 years after definitive surgical treatment. A random-effects regression model with repeated ordinal measurements was used to estimate the relationship between perceived risk of recurrence and demographic, medical, and psychosocial factors. We analyzed data from 535 patients [34% ductal carcinoma in situ (DCIS); 20% non-white] who reported their perceived risk at one or more interviews. At the first interview, 16% reported having no lifetime risk of recurrence, and another 16% reported ≥ 50% risk of recurrence, including 15% of DCIS patients. Patients who were white (OR = 5.88, 95% CI 3.39-10.19) and had greater state anxiety (OR = 1.04, 95% CI 1.02-1.07) were more likely, while patients who received radiotherapy (OR = 0.72, 95% CI 0.54-0.96) and had more social support (OR = 0.59, 95% CI 0.46-0.75) were less likely to report higher risk of recurrence. Cancer stage was not significantly associated with perceived risk of recurrence. Perceived risk of recurrence did not change significantly over time. Educating early-stage breast cancer patients about their actual risk could result in more realistic recurrence-risk perceptions, and increasing social support could help alleviate anxiety associated with exaggerated risk perceptions.

Download full-text


Available from: Mario Schootman,
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper a longitudinal output feedback tracker is developed for an aircraft and is shown to produce excellent performance for three different flight conditions without change of the control law matrices. The aircraft utilizes flight propulsion control coupling to provide greater control and responsiveness to command inputs. The singular perturbation method is applied to obtain an output-feedback digital multivariable control. Each flight condition has three command modes: positive pitch pointing, vertical translation, and straight climb. Decoupling of the outputs is demonstrated. A sensitivity study is performed to validate the robustness of the design and to illustrate design parameter influences on system response. The paper contains a summary of the control law design method. Since the CB matrix of the aircraft model does not have full rank, the use of a modified output feedback is used to obtain the required tracking performance.
    Decision and Control, 1982 21st IEEE Conference on; 01/1983
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast cancer is the most common type of cancer among women. Current clinical breast cancer diagnosis involves a biopsy, which is a costly, invasive and potentially painful procedure. Some researchers proposed models, based on mammography features and personal information, that help identify pre-biopsy invasive breast carcinoma and ductal carcinoma in situ (DCIS). Recently, a differential discriminating ability between invasive and DCIS has been linked to age. Based on this finding, we use an age-stratified mammography and biopsy relational dataset and apply Inductive Logic Programming (ILP) techniques to learn age-specific logical rules that classify invasive and DCIS occurrences. We then use statistical modeling to retrieve rules that have a significantly different performance across age-stratas. These final rules reveal a number of interesting results. Although a palpable lump is more commonly associated with younger patients, it turns out to be a better predictor of invasive cancer in older women. A recurrence has a higher probability to be invasive in older and middle-aged women. A previously unreported rule revealed by our technique is that recurrence is more likely a DCIS predictor in younger women. This younger DCIS predicting rule effectively links the current diagnostic mammogram to older studies, and provides opposite predictions across the age divide. The resulting rules are age-specific, can help patients and their physicians make more informed decisions about managing their breast health, and constitute a personalized predictive model.
    ACM International Health Informatics Symposium, IHI 2010, Arlington, VA, USA, November 11 - 12, 2010, Proceedings; 11/2010
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fear of cancer recurrence (FCR) is a common and persistent concern among breast cancer survivors. Little is known about factors associated with FCR in women with ductal carcinoma in situ (DCIS) or early invasive breast cancer (EIBC). Women with first primary DCIS, or stages I-IIA breast cancer were prospectively enrolled in a quality-of-life study and completed interviews at 4-6 weeks, 6 months, and 2 years after definitive surgical treatment. In three stepwise multivariable linear regression models, including both time-independent and time-varying variables measured at each respective interview, we identified independent correlates of mean FCR scores (range 1-6) using four items from the Concern About Recurrence Scale (CARS) at 2-year follow-up. Of 506 disease-free patients at 2-year follow-up (mean [SD] age, 58 [10] years; 81% White; 34% DCIS), the average FCR score of 2.0 was low. However, 145 (29%) reported moderate-to-high levels of FCR (scores 3.0-6.0). All three models showed that younger age, stage IIA breast cancer (vs. DCIS), lower social support, and elevated anxiety were consistently associated with higher FCR at 2-year follow-up (each P < 0.05; final models R (2) = 0.25-0.32). DCIS patients reported lower FCR than stage IIA patients (each P ≤ 0.01) but had similar FCR as stage I patients. Although mean FCR was low, 29% of DCIS and EIBC survivors reported moderate-to-high levels of FCR at 2-year follow-up. Management of anxiety, provision of social support, and patient education may help reduce FCR among DCIS and EIBC survivors, especially among younger survivors.
    Breast Cancer Research and Treatment 05/2011; 130(1):165-73. DOI:10.1007/s10549-011-1551-x · 3.94 Impact Factor
Show more